Defective sperm doubles the risk of preeclampsia
For the first time, researchers have linked specific frequent defects in sperm to elevated risk of pregnancy complications and negative impacts on the health of the baby. A… read more.
For the first time, researchers have linked specific frequent defects in sperm to elevated risk of pregnancy complications and negative impacts on the health of the baby. A… read more.
Johnson & Johnson announced that treatment with Tremfya (guselkumab) resulted in clear or almost clear skin in the majority of adults with low body surface area (BSA) moderate… read more.
Madrigal Pharmaceuticals, Inc. a biopharmaceutical company focused on delivering novel therapeutics for nonalcoholic steatohepatitis (NASH)/metabolic dysfunction-associated steatohepatitis (MASH), announced multiple resmetirom data presentations at the upcoming American Association… read more.
A recent commentary published in The Lancet journal highlights the critical importance of skeletal muscle mass in the context of medically induced weight loss, particularly with the widespread… read more.
PhD in Public Health candidate Elaine Russell and her mentor Kenneth Griffin, professor in the department of Global and Community Health, in George Mason University’s College of Public Health, worked with… read more.
Allergan Aesthetics, an AbbVie company announced the FDA approval of Botox Cosmetic for temporary improvement in the appearance of moderate to severe vertical bands connecting the jaw and… read more.
Young people diagnosed with severe obesity who had weight-loss surgery at age 19 or younger have achieved sustained weight loss 10 years later, researchers reported on Oct. 30,… read more.
Since their introduction last year, researchers have been monitoring the real-world impact of the new respiratory syncytial virus (RSV) vaccines. In a recent commentary in The Lancet, Angela Branche, MD,… read more.
Rigel Pharmaceuticals, Inc. announced it is issuing a Dear Health Care Provider (DHCP) letter related to a new safety signal for Gavreto (pralsetinib) after consultation with the FDA…. read more.
Women are more likely to receive good care during pregnancy where AI and other clinical software tools are used, a large review of research has found. In a… read more.
Pharmacists now have more guidance in combatting the opioid crisis and providing treatment to patients thanks to new national guidelines developed at the University of Houston College of… read more.
Positive data from the phase III LIBERTY-CUPID Study C evaluating the investigational use of Dupixent (dupilumab) in biologic-naive patients with uncontrolled chronic spontaneous urticaria (CSU) who receive background… read more.
If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.
You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.